Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Join Channel
Consolidated Standalone

Cipla

₹1489.2 13.3 | 0.9%

Market Cap ₹120270 Cr.

Stock P/E 28.9

P/B 4.1

Current Price ₹1489.2

Book Value ₹ 360.7

Face Value 2

52W High ₹1702

Dividend Yield 0.87%

52W Low ₹ 1236.6

Edit Ratio

Cipla Research see more...

Overview Inc. Year: 1935Industry: Pharmaceuticals & Drugs

Cipla Limited is an primarily India-based enterprise, usually engaged in the commercial enterprise of pharmaceuticals. The Company's segments consist of Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in growing, manufacturing, promoting and distributing widespread or branded accepted medicines, in addition to Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a customer healthcare, Biosimilars and distinctiveness enterprise. Its product portfolio spans complex generics, as well as drugs within the breathing, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, America, South Africa and Rest of the World. The Company has its community of manufacturing, buying and selling and different incidental operations in India and International markets. The Company has total of 46 manufacturing sites.

Read More..

Cipla Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Cipla Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Cipla Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 9457 10132 11951 10768 11390 12374 12659 11303 15381 14345 16574
Other Income 280 148 280 130 335 578 914 230 667 465 1071
Total Income 9737 10280 12231 10898 11725 12952 13573 11533 16048 14810 17645
Total Expenditure 7467 8170 9897 9172 9194 9872 9973 8235 11670 11000 12090
Operating Profit 2270 2109 2334 1726 2530 3080 3600 3298 4378 3810 5555
Interest 128 136 147 39 12 17 36 45 27 22 20
Depreciation 324 433 443 500 530 570 600 469 547 596 588
Exceptional Income / Expenses 0 0 0 0 -78 0 0 0 0 -186 0
Profit Before Tax 1818 1540 1744 1187 1911 2493 2964 2784 3804 3006 4947
Provision for Tax 430 359 282 212 443 604 646 739 922 862 1233
Profit After Tax 1388 1181 1462 975 1469 1888 2318 2045 2883 2144 3714
Adjustments 0 0 0 0 0 0 0 424 75 369 363
Profit After Adjustments 1388 1181 1462 975 1469 1888 2318 2468 2958 2513 4077
Adjusted Earnings Per Share 17.3 14.7 18.2 12.1 18.2 23.4 28.8 25.4 35.7 26.6 46

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 16% 14% 6% 6%
Operating Profit CAGR 46% 19% 13% 9%
PAT CAGR 73% 22% 14% 10%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 20% 17% 26% 9%
ROE Average 14% 12% 12% 12%
ROCE Average 19% 17% 17% 16%

Cipla Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 10092 11090 11986 12801 14114 15782 17403 19928 22514 24638 27974
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1706 2145 299 191 203 269 383 344 276 259 217
Total Current Liabilities 2417 3566 2954 2556 2732 2368 2619 2692 2632 2700 2862
Total Liabilities 14215 16802 15239 15548 17048 18419 20406 22964 25449 27596 31053
Fixed Assets 3524 3594 3826 4235 4320 4127 4025 3943 3847 3747 3603
Other Non-Current Assets 5593 6650 4946 4967 4790 4813 7354 8829 10169 10478 12543
Total Current Assets 5098 6559 6467 6345 7938 9477 9025 10191 11335 13371 14858
Total Assets 14215 16802 15239 15548 17048 18419 20406 22964 25449 27596 31053

Cipla Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 105 46 64 40 45 217 64 262 295 177 29
Cash Flow from Operating Activities 1812 1051 1728 2207 1117 1468 2018 3460 2773 3035 3727
Cash Flow from Investing Activities -1467 -1194 -1206 -1191 -592 -1147 -1126 -3360 -2464 -2758 -2883
Cash Flow from Financing Activities -404 180 -547 -1011 -351 -473 -694 -66 -427 -425 -709
Net Cash Inflow / Outflow -59 37 -24 5 173 -152 198 34 -117 -148 135
Closing Cash & Cash Equivalent 46 83 40 45 217 64 262 295 177 29 165

Cipla Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 17.29 14.71 18.2 12.12 18.24 23.44 28.75 25.35 35.73 26.56 46
CEPS(Rs) 21.32 20.1 23.71 18.33 24.82 30.51 36.19 31.16 42.5 33.95 53.28
DPS(Rs) 2 2 2 2 3 3 4 5 5 8.5 13
Book NAV/Share(Rs) 125.31 137.12 148.08 158.37 174.63 195.35 215.43 246.66 278.59 304.76 345.95
Core EBITDA Margin(%) 20.82 19.18 16.95 14.55 19.18 19.18 19.82 25.21 22.77 22.21 25.65
EBIT Margin(%) 20.37 16.39 15.61 11.17 16.8 19.24 22.13 23.25 23.51 20.11 28.41
Pre Tax Margin(%) 19.03 15.06 14.39 10.82 16.7 19.11 21.87 22.88 23.34 19.96 28.3
PAT Margin (%) 14.53 11.55 12.07 8.88 12.83 14.48 17.1 16.8 17.69 14.24 21.24
Cash Profit Margin (%) 17.91 15.79 15.72 13.44 17.46 18.85 21.53 20.66 21.04 18.2 24.61
ROA(%) 10.53 7.62 9.13 6.33 9.01 10.65 11.94 9.43 11.91 8.08 12.67
ROE(%) 14.67 11.21 12.77 7.91 10.96 12.67 14 10.97 13.61 9.11 14.14
ROCE(%) 18.73 14.31 14.79 9.34 14.03 16.69 18.08 15.15 18.05 12.84 18.88
Receivable days 64.42 67.48 59.47 63.78 68.17 77.02 90.59 98.93 65.28 68.88 58.15
Inventory Days 92.71 103.53 93.49 92.66 90.76 82.64 79.3 91.6 73.59 81.97 68.18
Payable days 112.48 133.27 109.33 128.04 160.5 156.18 169.73 184.38 117.14 162.93 155.96
PER(x) 22.19 48.35 28.14 48.88 29.78 22.58 14.71 32.16 28.51 33.91 32.49
Price/Book(x) 3.06 5.19 3.46 3.74 3.11 2.71 1.96 3.31 3.66 2.96 4.32
Dividend Yield(%) 0.52 0.28 0.39 0.34 0.55 0.57 0.95 0.61 0.49 0.94 0.87
EV/Net Sales(x) 3.35 5.76 3.53 4.45 3.84 3.43 2.65 5.74 5.25 5 7.26
EV/Core EBITDA(x) 13.94 27.69 18.1 27.76 17.26 13.79 9.33 19.67 18.44 18.83 21.66
Net Sales Growth(%) 15.29 7.14 17.95 -9.89 5.77 8.64 2.3 -10.72 36.08 -6.73 15.54
EBIT Growth(%) -4.84 -13.88 12.83 -35.16 56.86 30.49 19.55 -5.71 35.43 -20.97 64.05
PAT Growth(%) -7.88 -14.93 23.81 -33.33 50.63 28.59 22.76 -11.8 40.98 -25.62 73.23
EPS Growth(%) -7.88 -14.93 23.74 -33.42 50.51 28.5 22.67 -11.82 40.92 -25.65 73.19
Debt/Equity(x) 0.09 0.13 0.1 0.03 0.01 0 0 0 0 0 0
Current Ratio(x) 2.11 1.84 2.19 2.48 2.91 4 3.45 3.79 4.31 4.95 5.19
Quick Ratio(x) 1.09 0.93 1.2 1.44 1.79 2.79 2.29 2.64 2.98 3.74 4.05
Interest Cover(x) 15.22 12.32 12.86 31.28 161.62 147.9 83.23 62.77 142.27 135.96 245.29
Total Debt/Mcap(x) 0.03 0.02 0.03 0.01 0 0 0 0 0 0 0

Cipla Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoter 33.42 33.41 33.41 33.41 33.4 33.4 33.4 33.4 30.86 30.86
FII 27.48 27.52 28.21 27.29 25.44 25.69 25.68 25.77 27.77 28.74
DII 21.22 21.56 20.96 21.96 24.22 24.06 24.22 24.3 24.84 24.04
Public 17.3 16.91 16.81 16.92 16.73 16.64 16.5 16.32 16.37 16.16
Others 0.59 0.6 0.61 0.42 0.2 0.21 0.21 0.21 0.16 0.21
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 162.93 to 155.96days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 30.86%.
  • Company has a low return on equity of 12% over the last 3 years.
  • Stock is trading at 4.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Cipla News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!